Interim Consolidated Balance Sheets (USD $)	Mar. 31, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$ 344	$ 1,094
Accounts receivable
Total current assets	344	1,094
Technology intellectual property	10,025,500
TOTAL ASSETS	10,025,844	1,094
Liabilities
Accounts payable and accrued liabilities	558,301	530,353
Debenture payable	480,624	480,624
Note payable to related party	171,681	187,931
Due to related parties	10,167,771	174,222
Total Liabilities	11,378,377	1,373,130
Stockholders' deficiency
Capital Stock Authorized - 750,000,000 common shares, $0.00001 par value Issued and outstanding March 31, 2013 – 41,452,147 common shares, $0.00001 par value December 31, 2012 – 1,151,937 common shares, $0.00001 par value	415	12
Shares to be issued	(60,000)	(60,000)
Additional paid-in capital	9,473,284	9,408,186
Accumulated other comprehensive loss	5,776	5,776
Deficit, accumulated during the exploration stage	(10,880,456)	(10,834,458)
Total Stockholders' Equity (Deficit)	(1,352,533)	(1,372,036)
TOTAL LIABILITIES & DEFICIT	$ 10,025,844	$ 1,094